Carl June (Brian Ach/Getty Images for TIME 100 Health Summit)

UPenn and Stan­ford analy­sis finds no sec­ondary can­cer cas­es di­rect­ly due to CAR-T

The Uni­ver­si­ty of Penn­syl­va­nia’s pi­o­neer­ing cell ther­a­py physi­cian Carl June shared new da­ta Mon­day that showed the risk of sec­ondary can­cers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.